All Stories

  1. The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

    Article • OncoTargets and Therapy, March 2018, Dove Medical Press

    Ruolan Qian, Peng Luo

  2. The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer

    Article • Drug Design Development and Therapy, November 2017, Dove Medical Press

    Peng Luo, Ruolan Qian